Use access key #2 to skip to page content.
  • S&P 500: 1,091.38
  • Change: -0.32%
$41.71 -0.29 (-0.69%)
11/20/2009 4:00 PM

Gen-Probe, Inc. (GPRO)

CAPS Rating:
***

The Company is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid probe-based products used for the clinical diagnosis of human diseases and for screening donated human blood.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating GPRO

Add Stock to Watchlist

What the Community Thinks

Total Members

220 Outperforms
10 Underperforms
 

All-Stars

64 Outperforms
3 Underperforms
 

Wall Street

16 Outperforms
0 Underperforms
 

Members bullish on GPRO are also bullish on:

Members bearish on GPRO are also bearish on:

Ticker Tags

Defensive (1498), In Vitro Diagnostics (1), Medical Diagnostic Equipment (11), Healthcare Equipment and Supplies (179), Growth (1883), Small Cap (1582), Healthcare (733)
Suggest a tag

Gen-Probe, Inc. At A Glance

Current Price: $41.71
Last Trade Time: 11/20/2009 4:00 PM
Open: $41.65
Previous Close: $42.00
Daily Range: $41.65 - $41.97
52-Week Range: $30.01 - $49.29
Volume: 326,562
Market Cap: $2.05B
P/E Ratio: 24.14
Compare Our Special Broker Offers!

Stock Trends

GPRO VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

2

Gen-Probe, Inc. (GPRO)

Avatar doggetla (< 20) Submitted: 3/24/08 6:49 PM

just "discovered" this stock, healthcare is the sector to be in during a recession.

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 22 :   1 2 3 4 5 Next »

Recs

0

 (GPRO)

Avatar kevinottofro (98.74) Submitted: 11/07/09 8:43 AM : Outperform Start Price: $41.39 GPRO Score: -0.60

low relative PE, good star & 2010 earnings. Bottom fishing week of 10/26.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GPRO)

Avatar hardrockfool (< 20) Submitted: 11/02/09 3:09 PM : Outperform Start Price: $40.95 GPRO Score: -3.35

Their H1N1 flu test was just emergency approved by the FDA.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GPRO)

Avatar NewlyMinted4Star (< 20) Submitted: 10/26/09 2:27 PM : Outperform Start Price: $42.54 GPRO Score: -4.49

This account tracks the performance of newly minted 4 star stocks - 3 star stocks that recently turned in to 4 star stocks.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GPRO)

Avatar Prodders (< 20) Submitted: 10/06/09 5:11 PM : Outperform Start Price: $44.99 GPRO Score: -11.24

Great growth business with a very reasonable valuation. Could do the business for years.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GPRO)

Avatar visibleinvesting (56.16) Submitted: 8/10/09 12:53 AM : Outperform Start Price: $37.84 GPRO Score: 1.08

GPRO's patented testing will save government, insurance companies, individuals money. These products and services are going at the heart of the health care system. this company is selling for 50 cents on the dollar because of some short term, non repeatable problems. It's not often you can invest in a company with the economics and social impact of GPRO at such a low valuation.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 22 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 16 of 16  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackWMBlair < 20 10/07/09 Outperform NS $44.99-7.29%+3.95%-11.24
TrackOppenheimer < 20 09/10/09 Outperform NS $39.00+6.95%+6.62%+0.33
TrackMaximGroup < 20 07/30/09 Outperform NS $42.00-0.69%+11.25%-11.94
TrackBarclaysCap 86.21 01/08/09 Outperform NS $40.77+2.31%+23.37%-21.06
TrackCarisandCo 76.69 04/29/08 Outperform NS $56.84-26.62%-18.68%-7.94
TrackRBCCapMkts 82.07 04/23/08 Outperform NS $54.30-23.19%-17.93%-5.25
TrackDeutscheSec 87.23 11/15/07 Outperform NS $63.32-34.13%-21.78%-12.35
TrackRonBaron < 20 09/30/07 Outperform NS $66.58-37.35%-24.86%-12.50 Toggle the visibility of 60-Second Pitch and replies
TrackSoros 24.12 09/30/07 Outperform NS $66.58-37.35%-24.86%-12.50 Toggle the visibility of 60-Second Pitch and replies
TrackFerrisBaker 57.55 08/02/07 Outperform NS $65.18-36.01%-21.24%-14.77
TrackJimCramer 36.31 07/12/07 Outperform 3W $59.98-30.46%-25.39%-5.07
TrackGarpResearc 83.75 04/17/07 Outperform NS $50.73-17.78%-21.36%+3.58
TrackBofASec 91.37 04/13/07 Outperform NS $49.06-14.98%-20.15%+5.17
Track2007Wired40 91.73 03/27/07 Outperform 1Y $47.30-11.82%-19.02%+7.20
TrackLehmanBros 66.51 11/20/06 Outperform NS $49.25-15.31%-17.18%+1.87
Track2006Wired40 96.65 06/27/06 Outperform 1Y $51.33-18.74%-5.82%-12.92

Results 1 - 16 of 16  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD01 750ms